Every year, drug prices increase and 2024 is no exception
We think that is particularly important in prostate cancer because the volume of fat that sits around the prostate is very clearly linked with poorer drug response in patients and a faster disease progression and spread outside of the prostate. GLP1 drugs are considered very effective but can cause a predictable cluster of gastrointestinal effects and a smaller set of more serious, less common risks that need watching. Medicare currently covers GLP1 drugs (like Ozempic, Mounjaro, and sometimes Wegovy/Zepbound) only when they are used for approved medical indications such as type 2 diabetes or cardiovascular risk reduction not for weight loss alone
Adults in their 20s or 30s who are aging faster than they should due to chronic stress, poor sleep, or lifestyle factors, or simply want to be proactive in protecting their long-term health
However, it is a different story when stress persists and adrenal fatigue sets in
In the landmark SURMOUNT-1 trial, participants on the 15 mg dose achieved average weight loss of 22.5% of body weight over 72 weeks